European equities traded in the US as American depositary receipts were up sharply late Thursday morning, rising 1.25% to 1,372.71 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company Genfit (GNFT), which climbed 7.3% and 4.1% respectively. They were followed by pharmaceutical company Sanofi (SNY) and electronics conglomerate Philips (PHG), which were up 3.4% and 2.6% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and accommodations booking company trivago (TRVG), which fell 27.7% and 2.5% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP (EDAP), which were down 1.5% each.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and Prudential (PUK), which rose 4.1% and 3.5% respectively. They were followed by educational publisher Pearson (PSO) and oil and gas company Shell (SHEL), which increased 3.2% and 3% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which dropped 13.3% and 5.3% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO), which lost 2.2%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。